Background: Non-invasive fractional flow reserve (FFR) derived from typically acquired coronary computed tomographic (CT) angiography (FFRCT) is a novel method that employs computational fluid dynamics to diagnose coronary lesions that cause ischemia. To date, the diagnostic performance of FFRCT versus CT stenosis to effectively diagnose ischemia in vessels with stenosis of intermediate severity (30-70% luminal diameter stenosis) has been inadequately studied. Methods: Amongst 407 vessels from 252 patients at 17 centers in 4 countries who underwent CT, FFRCT, invasive coronary angiography and invasive FFR, we identified 150 vessels of intermediate stenosis severity by CT. CT stenosis, FFRCT, and invasive FFR were interpreted in blinded fashion by independent core laboratories. FFRCT and FFR Ͻ0.80 were considered ischemic, while CT stenosis Ͼ50% were considered obstructive. Diagnostic performance of CT stenosis alone versus FFRCT alone were evaluated for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV); as well as employing a decision rule combining FFRCT and CT stenosis wherein maximal per-patient CT stenosis Ͻ30% was considered negative for ischemia and subtotal or total occlusions were considered positive for ischemia. Area under the receiver operating characteristics curve for FFRCT and CT stenosis were compared for discrimination. Results: For lesions of intermediate stenosis severity, FFRCT demonstrated a sensitivity, specificity, PPV and NPV of 74%, 66%, 40%, and 89%; while CT stenosis demonstrated a sensitivity, specificity, PPV and NPV of 34%, 72%, 27%, 78%. When applying the decision rule, the combination of FFRCT and CT stenosis resulted in a sensitivity, specificity, PPV and NPV of 74%, 67%, 39% and 90%. The AUC of FFRCT for discrimination of ischemia in stenoses of intermediate severity was higher than CT stenosis (0.80 vs. 0.55, pϽ0.0001), with no added improvement when CT stenosis was added to FFRCT (0.81 vs. 0.80). Conclusions: Compared to CT, FFRCT possesses higher diagnostic performance for lesions of intermediate severity, with a Ͼ2X increase in sensitivity and superior NPV, suggesting its role to identify lesions that are not ischemic. Background: Previous IVUS studies examining correlates of drug-eluting stent (DES) thrombosis were retrospective and in small patient cohorts. Methods: ADAPT-DES was a prospective, multicenter, real-world registry of 8,575 consecutive pts at 11 international centers treated with percutaneous coronary intervention (PCI) using DES designed to determine the frequency, timing, and correlates (clinical, angiographic and platelet reactivity) of early and late DES thrombosis. A pre-specified IVUS substudy enrolled 2,438 IVUS-guided PCI lesions in 2,064 pts; baseline grayscale volumetric IVUS analysis was prospectively done at an independent core laboratory, and 1-year follow-up was completed. Results: Average pt age was 64.0 years and 75.4% were male. Stent thrombosis (ST) occurred in 10 pts (0.5%); 7 definite and 3 probable (median 14.5 days). ST lesions had more attenuated plaque -a grayscale IVUS marker of a large necrotic core or a thin-cap fibroatheroma -along with greater tissue protrusion through the stent into the lumen, reference plaque burden and edge dissections (Table) . Minimum lumen area, stent expansion, and acute malapposition were similar in ST vs no ST.
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